Large-scale testing (Phase 3)Study completedNCT04777409
What this trial is testing
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Who this might be right for
Early Alzheimer´s Disease
Novo Nordisk A/S 1,840